Literature DB >> 33802627

KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma.

Julia Ingruber1, Dragana Savic2,3, Teresa Bernadette Steinbichler1, Susanne Sprung4, Felix Fleischer1,5, Rudolf Glueckert1, Gabriele Schweigl1, Ira-Ida Skvortsova2,3, Herbert Riechelmann1, József Dudás1.   

Abstract

Epithelial to mesenchymal transition (EMT) is clinically relevant in head and neck squamous cell carcinoma (HNSCC). We hypothesized that EMT-transcription factors (EMT-TFs) and an anti-EMT factor, Krüppel-like-factor-4 (KLF4) regulate EMT in HNSCC. Ten control mucosa and 37 HNSCC tissue samples and three HNSCC cell lines were included for investigation of EMT-TFs, KLF4 and vimentin at mRNA and protein levels. Slug gene expression was significantly higher, whereas, KLF4 gene expression was significantly lower in HNSCC than in normal mucosa. In the majority of HNSCC samples, there was a significant negative correlation between KLF4 and Slug gene expression. Slug gene expression was significantly higher in human papilloma virus (HPV) negative HNSCC, and in tumor samples with irregular p53 gene sequence. Transforming-growth-factor-beta-1 (TGF- β1) contributed to downregulation of KLF4 and upregulation of Slug. Two possible regulatory pathways could be suggested: (1) EMT-factors induced pathway, where TGF-β1 induced Slug together with vimentin, and KLF4 was down regulated at the same time; (2) p53 mutations contributed to upregulation and stabilization of Slug, where also KLF4 could co-exist with EMT-TFs.

Entities:  

Keywords:  FaDu; SCC-25; TWIST; TissueFaxs; UPCI-SCC090; ZEB

Year:  2021        PMID: 33802627      PMCID: PMC7998447          DOI: 10.3390/cells10030539

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  38 in total

1.  p53 modulates NF-κB mediated epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.

Authors:  Yuan Lin; Jon Mallen-St Clair; Jie Luo; Sherven Sharma; Steven Dubinett; Maie St John
Journal:  Oral Oncol       Date:  2015-08-22       Impact factor: 5.337

2.  Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.

Authors:  Pavla Bouchalova; Rudolf Nenutil; Petr Muller; Roman Hrstka; M Virginia Appleyard; Karen Murray; Lee B Jordan; Colin A Purdie; Philip Quinlan; Alastair M Thompson; Borivoj Vojtesek; Philip J Coates
Journal:  J Pathol       Date:  2014-05-21       Impact factor: 7.996

Review 3.  The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology.

Authors:  Beth B McConnell; Amr M Ghaleb; Mandayam O Nandan; Vincent W Yang
Journal:  Bioessays       Date:  2007-06       Impact factor: 4.345

Review 4.  HPV, hypoxia and radiation response in head and neck cancer.

Authors:  Eva-Leonne Göttgens; Christian Ostheimer; Paul N Span; Jan Bussink; Ester M Hammond
Journal:  Br J Radiol       Date:  2018-03-14       Impact factor: 3.039

Review 5.  EMT and Cancer: More Than Meets the Eye.

Authors:  Rik Derynck; Robert A Weinberg
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 12.270

6.  p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug.

Authors:  Shu-Ping Wang; Wen-Lung Wang; Yih-Leong Chang; Chen-Tu Wu; Yu-Chih Chao; Shih-Han Kao; Ang Yuan; Chung-Wu Lin; Shuenn-Chen Yang; Wing-Kai Chan; Ker-Chau Li; Tse-Ming Hong; Pan-Chyr Yang
Journal:  Nat Cell Biol       Date:  2009-05-17       Impact factor: 28.824

7.  Fibroblasts produce brain-derived neurotrophic factor and induce mesenchymal transition of oral tumor cells.

Authors:  József Dudás; Mario Bitsche; Volker Schartinger; Christina Falkeis; Georg Mathias Sprinzl; Herbert Riechelmann
Journal:  Oral Oncol       Date:  2010-12-13       Impact factor: 5.337

Review 8.  New developments in the management of head and neck cancer - impact of pembrolizumab.

Authors:  Khalil Saleh; Roland Eid; Fady Gh Haddad; Nadine Khalife-Saleh; Hampig Raphaël Kourie
Journal:  Ther Clin Risk Manag       Date:  2018-02-19       Impact factor: 2.423

9.  Slug Is A Surrogate Marker of Epithelial to Mesenchymal Transition (EMT) in Head and Neck Cancer.

Authors:  T B Steinbichler; J Dudas; J Ingruber; R Glueckert; S Sprung; F Fleischer; N Cidlinsky; D Dejaco; B Kofler; A I Giotakis; I I Skvortsova; H Riechelmann
Journal:  J Clin Med       Date:  2020-06-30       Impact factor: 4.241

10.  Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma.

Authors:  József Dudás; Anna Riml; Raphaela Tuertscher; Christian Pritz; Teresa Bernadette Steinbichler; Volker Hans Schartinger; Susanne Sprung; Rudolf Glueckert; Anneliese Schrott-Fischer; Lejo Johnson Chacko; Herbert Riechelmann
Journal:  Int J Mol Sci       Date:  2019-01-11       Impact factor: 5.923

View more
  4 in total

Review 1.  Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition.

Authors:  Oleg Semenov; Alexandra Daks; Olga Fedorova; Oleg Shuvalov; Nickolai A Barlev
Journal:  Front Mol Biosci       Date:  2022-06-23

2.  HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab.

Authors:  Andrea Ladányi; Barbara Hegyi; Tímea Balatoni; Gabriella Liszkay; Raphael Rohregger; Christoph Waldnig; József Dudás; Soldano Ferrone
Journal:  Pathol Oncol Res       Date:  2022-04-22       Impact factor: 2.874

3.  Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines.

Authors:  Maria do Carmo Greier; Annette Runge; Jozsef Dudas; Viktoria Pider; Ira-Ida Skvortsova; Dragana Savic; Herbert Riechelmann
Journal:  Sci Rep       Date:  2022-08-02       Impact factor: 4.996

4.  SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival.

Authors:  Henrik Schinke; Min Pan; Merve Akyol; Jiefu Zhou; Enxian Shi; Gisela Kranz; Darko Libl; Tanja Quadt; Florian Simon; Martin Canis; Philipp Baumeister; Olivier Gires
Journal:  Mol Oncol       Date:  2021-08-21       Impact factor: 6.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.